Opioid substitution treatment increases chances that people who inject drugs will have good adherence to HIV therapy
HCV sexual transmission linked to anal sex, drug use, lower CD4 count
Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection
Young drug injectors on opioid maintenance therapy have lower risk of hepatitis C infection
Expanded harm reduction provision achieves impressive reductions in HCV incidence among PWID in Scotland
Harm reduction prevents HIV, national evidence from Ukraine and Greece shows
Interferon-free hepatitis C treatment works for people on methadone or buprenorphine
Harm reduction funding meeting only 7% of global need
Recession and income inequality have fuelled HIV infections in European drug users
